FDA Warns against Triamcinolone and Moxifloxacin injections in Eye Ruby Khatun Khatun8 Aug 2017 9:18 AM ISTThe U.S. Food and Drug Administration (FDA) received adverse event reports on April 5 and June 1, 2017, and conducted follow-up, concerning at least...
Senate reauthorizes FDA to collect fees from drugmakers Ruby Khatun Khatun8 Aug 2017 9:15 AM ISTThe U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new...
WHO prequalifies first generic hepatitis C medicine and first HIV self-test Ruby Khatun Khatun7 Aug 2017 10:20 AM ISTWHO prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to...
3.16 percent of drugs in India not of standard quality, admits Ministry Ruby Khatun Khatun7 Aug 2017 10:06 AM ISTMinister of State for Road Transport & Highways, Shipping and Chemicals & Fertilizers, Shri Mansukh L. Mandaviya, in a written reply to the...
FDA approves Imbruvica to treat chronic graft versus host disease Ruby Khatun Khatun7 Aug 2017 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft...
NPPA re-fixes price of Bactrafuz-M cream Ruby Khatun Khatun7 Aug 2017 9:30 AM ISTThrough a recent corrigendum, NPPA had re-fixed the price of Fusidic Acid + Mometasone Furoate (Bactrafuz-M cream).Medical Dialogues had earlier...
hCue joins hand with CAMS to Help Pharmacy Retailers and Distributors Across India Ruby Khatun Khatun7 Aug 2017 9:19 AM ISTChennai: CAMS (Computer Age Management Services), a leading and integral part of Indian financial infrastructure co-owned by NSE Strategic Investment...
FDA panel votes against approval of J&J arthritis drug Ruby Khatun Khatun7 Aug 2017 9:18 AM ISTThe benefits of Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks, an advisory panel to the U.S. Food...
Eli Lilly acute migraine drug succeeds in late-stage study Ruby Khatun Khatun7 Aug 2017 9:18 AM ISTDrugmaker Eli Lilly and Co said on Friday its acute migraine drug lasmiditan succeeded in a key late-stage study, setting the stage for U.S....
Pharma stocks under pressure, fall up to 5 percent Ruby Khatun Khatun7 Aug 2017 9:16 AM ISTNew Delhi: Pharma stocks were under selling pressure, falling up to 5 per cent, led by Biocon and Dr Reddy's Lab.Shares of Morepen Laboratories fell...
Regeneron beats profit view, to end antibody deal with Sanofi Ruby Khatun Khatun7 Aug 2017 9:15 AM ISTRegeneron Pharmaceuticals Inc reported a much better-than-expected quarterly profit on strong demand for its flagship Eylea drug and said it would end...
Why No investigation against Roche for anti-competitive practices, questions HC Ruby Khatun Khatun6 Aug 2017 11:00 AM ISTNew Delhi: Can truth in vilification of a competitor be a defence against allegation of anti-competitive conduct. This was the poser by Delhi High...
